Morgan Stanley’s Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share DNA.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $29 | Sell |
|
|||||
|
2024
Q1 | $64.7K | Sell |
|
|||||
|
2023
Q4 | $151K | Buy |
|
|||||
|
2023
Q3 | $162K | Hold |
|
|||||
|
2023
Q2 | $188K | Hold |
|
|||||
|
2023
Q1 | $129K | Hold |
|
|||||
|
2022
Q4 | $144K | Sell |
|
|||||
|
2022
Q3 | $518K | Hold |
|
|||||
|
2022
Q2 | $381K | Hold |
|
|||||
|
2022
Q1 | $633K | Hold |
|
|||||
|
2021
Q4 | $1.61M | Buy |
|
|||||
|
2021
Q3 | $2.44M | Buy |
|